VALENCIA, Calif., Feb. 20, 2018 /PRNewswire/ -- Bioness, Inc., the leading provider of cutting-edge, clinically supported rehabilitation therapies, today announced it will feature its full suite of ...

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness Inc., a leading neuromodulation company, announced today two agreements to distribute new devices for patients experiencing neurological impairment. Through ...

DURHAM, N.C., March 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc. (“Bioness”), ...

Bioventus Inc. has acquired medical devices provider Bioness Inc. for a total consideration of $110 million. This includes an up-front payment of $45 million and milestone payments of up to $65 ...

DURHAM – Global medical technology company Bioventus, which went public earlier this year, is growing bigger with an acquisition. The company announced Tuesday it had acquired California-based Bioness ...

VALENCIA, California, Feb. 18, 2019 /PRNewswire/ -- Bioness, Inc., the leading provider of advanced, clinically supported medical devices for the treatment of chronic pain of peripheral nerve origin, ...

VALENCIA, Calif., June 18, 2025 /PRNewswire/ -- Bioness Medical, Inc. ("Bioness", or the "Company") a leading neuro-rehabilitation Company aiming to improve and restore function for those living with ...

The Bioness devices have helped her walk better - and allowed her to wear normal shoes. She has been receiving training on two Bioness products at Memorial Hospital: the Ness H200 hand unit and the ...

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness Inc. today announced that its Board of Directors has named Todd Cushman as the company’s President and CEO in an effort to refine its strategy and reorganize ...

Pain Treatments and Joint Preservation includes the legacy Osteoarthritis (OA) Joint Pain Treatment and Joint Preservation products, plus the Bioness Peripheral Nerve Stimulation products. Restorative ...

Bioventus Inc. has acquired medical devices provider Bioness Inc. for a total consideration of $110 million. This includes an up-front payment of $45 million and milestone payments of up to $65 ...